Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
We cover the top budgeting pitfalls and simple methods to prevent them, helping you maintain accuracy and momentum in your plan.
17,089 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
When a top executive sells a large block of shares, investors want clarity. This guide breaks down what RingCentral's...
Amazon's potential shift to selling its Trainium AI chips could shake up the AI hardware landscape. This article brea...
XRP is slipping again as macro risk-off tones and a large pool of underwater holders keep a lid on rallies. Analysts ...
A veteran fund manager challenges Wall Street's reliance on earnings when valuing AI plays, arguing that the E in P/E...
Micron Technology races higher on AI memory demand and supply tightness. This piece outlines why investors may consid...
Late-career workers who enroll in Medicare while still employed and continue HSA deposits risk a 6% annual excise tax...
Investors are weighing bloom energy stock: buy options as the company scales its solid oxide fuel cells for AI data c...
OpenAI’s fresh developments could tilt the landscape for AI hardware suppliers. This guide explains what Broadcom sto...
Unlock a practical framework for interpreting bridger aerospace (BAER) earnings. This guide breaks down revenue drive...
The FTSE Russell semi-annual rebalancing will drive heavy trading as index funds realign weights. Markets brace for v...
Analysts say ethereum price predictions analyst signals point to a potential rebound as ETH tests a key support, with...